Prudential Financial Inc Solid Biosciences Inc. Transaction History

Prudential Financial Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.43 - $1.24 $19,866 - $57,288	46,200 New	46,200 $28,000
Q4 2021 Feb 14, 2022	SELL	$1.69 - $2.46 $17,695 - $25,758	-10,471 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.38 - $3.77 $24,920 - $39,475	10,471 New	10,471 $25,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $29.8M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.